DLBCL
Showing NaN - NaN of 6
Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)
Recruiting
- NSCLC
- +6 more
- Oral MRT-2359
-
Scottsdale, Arizona
- +7 more
Dec 20, 2022
DLBCL Trial in United States (MB-CART2019.1)
Recruiting
- DLBCL
- MB-CART2019.1
-
Gilbert, Arizona
- +14 more
Jun 17, 2022
DLBCL, Neurotoxicity Syndromes Trial in United States (Defibrotide)
Terminated
- DLBCL
- Neurotoxicity Syndromes
-
Phoenix, Arizona
- +4 more
Nov 10, 2021